08 May 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis
Yi Zhou123ACDE, Yantao Ding123BCDE, Mengxing Cui4F, Yuanjing Zhang123BCD, Mengwei Wang32B, Feiran Zhou5F, Yi Su6F, Bo Liang123ACDG*, Fusheng Zhou123ACDDOI: 10.12659/MSM.943360
Med Sci Monit 2024; 30:e943360
Figure 3 Lipid metabolic alterations in patients with psoriasis after methotrexate (MTX) treatment(A) Principal component analysis plot clearly separating samples from 0 and 12 weeks of MTX treatment in cohort 1. (B) Volcano plot showing 139 differentially expressed metabolites. (C) Three representative lipids were significantly altered after 12 weeks of MTX treatment. Each dot indicates an individual. The 1 quantile and mean and 3 quantile levels are shown in the boxplot. (D) Metabolic pathways showed that the differentially expressed lipids are prominent in the glycerophospholipid pathway. (Figures were generated by R with ggplot2_3.4.2, EnhancedVolcano_1.16.0. The metabolic pathways analysis was based on MetaboAnalyst 6.0.).






